(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Suramin analogues induce aggregation of purified recombinant mouse prion protein. (A,B) Recombinant mouse PrP (amino acids 23-231) (50 ng/µl) was incubated overnight with 10 or 100 µg/ml of the suramin analogues indicated in sodium acetate buffer at pH 7. Samples were then subjected to ultracentrifugation in the presence of 1% sarcosyl. Pellets and supernatants were run on SDS-PAGE and analysed by immunoblotting using the mouse monoclonal antibody 4H11. Mock-treated recombinant PrP was detected in the soluble as well as in the insoluble fractions. Upon treatment with NF023, NF449, NF078, NF110, NF305, NF068 and suramin, a clear shift into pellet fractions was detected whereas ANTS (B, lanes 5-8) and NF043 (B, lanes 13-16) did not affect the solubility of PrP.